While these results are encouraging and innovative, our data indicate that PDAC tumor-associated pericytes and PDAC Exo-treated pericytes do not express significant levels of Rgs-5, emphasizing pericyte heterogeneity across the different types of tumors. The gene discussed is RGS5; the disease is neoplasm.